Cashu
Gyre Therapeutics Collaborates with Harbour BioMed to Advance Antibody Therapeutics Development
about 1 month ago
Stocks
Health Care
gyre
Gyre Therapeutics
NASDAQ: GYRE
+0.36 (+4.56%)
8.26
USD
At close at Mar 04, 21:39 UTC
Latest Gyre Therapeutics News
prnewswire.com
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
about 2 months ago
prnewswire.com
Neurocrine Biosciences Presents Head-to-Head INGREZZA (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR
about 2 months ago
prnewswire.com
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
about 2 months ago
prnewswire.com
IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference
about 2 months ago
prnewswire.com
Nona Biosciences Enters into Collaboration Agreement with Link Cell Therapies to Advance CAR-T Cell Therapies
about 2 months ago
prnewswire.com
Innovent's Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration
about 2 months ago
benzinga.com
6 Analysts Have This To Say About Harmony Biosciences Hldgs
about 2 months ago
prnewswire.com
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases
about 2 months ago
benzinga.com
Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday
about 2 months ago
benzinga.com
Bright Minds Biosciences, Praxis Precision Medicines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
about 2 months ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.